FDA Drug recall D-1066-2014
The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry
- FDA Drug
- Class II
- terminated
- Published 2014-02-12
On 2014-02-12 the FDA classified a Class II recall of The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry by Apothecure, citing lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during a….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1066-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-04-15 |
| Published | 2014-02-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Apothecure |
| Distribution | US |
Product
The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry.
Reason
Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
Identifiers
| code_info | All Lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1066-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.